Rispide 1 Mg/Ml 1 mg Oral solution
PDF Leaflet Revision Date: 13 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of schizophrenia, mania in bipolar disorder, and disruptive behavior disorders in children.
Dosage (summary)
Adults: Start at 2 mg/day, increase to 4 mg/day on day 2, maintain 4-8 mg/day. Elderly/Renal/Hepatic: Start at 0.5 mg twice daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if benefits outweigh risks; contraindicated in breastfeeding.
Key Drug Interactions
- CYP2D6 inhibitors
- CYP3A4 inhibitors
- Centrally acting substances
Contraindications
- Hypersensitivity to risperidone
- Children under 5 years
- Parkinsonu2019s disease
- Lewy Body dementia
Common side effects
- Sedation
- Parkinsonism
- Weight gain
- Hyperprolactinaemia
Counselling Points
- Monitor for sedation
- Avoid alcohol
- Regular weight checks
- Report signs of hyperglycaemia
Serious warnings
- Increased mortality in elderly with dementia
- Neuroleptic malignant syndrome
- Cerebrovascular adverse events
Important Disclaimer
The Rispide 1 Mg/Ml 1 mg Oral solution professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
